SCHEMBL29655130

SCHEMBL29655130

Nc1ccc(-c2cc(Cc3n[nH]c(=O)c4ccccc34)ccc2F)cc1[N+](=O)[O-]

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 2/20 0.52
PARP1 P09874 14/20 0.50
PARP2 Q9UGN5 2/20 0.50
TUBB4A P04350 1/20 0.50
TUBB P07437 1/20 0.50
TUBA3C P0DPH7 1/20 0.50
TPI1 P60174 1/20 0.50
TUBA1B P68363 1/20 0.50
TUBA4A P68366 1/20 0.50
TUBB4B P68371 1/20 0.50
TUBB3 Q13509 1/20 0.50
TUBB2A Q13885 1/20 0.50
TUBB8 Q3ZCM7 1/20 0.50
TUBA3E Q6PEY2 1/20 0.50
TUBA1A Q71U36 1/20 0.50
TUBA1C Q9BQE3 1/20 0.50
TUBB6 Q9BUF5 1/20 0.50
TUBB2B Q9BVA1 1/20 0.50
TUBB1 Q9H4B7 1/20 0.50
ENPP1 P22413 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19748384 1.00 AR (0.52) ARPARP1PARP2TUBB4ATUBB
SCHEMBL19748896 0.93 AR (0.51) ARPARP1PARP2TUBB4ATUBB
SCHEMBL29655126 0.93 AR (0.51) ARPARP1PARP2TUBB4ATUBB
SCHEMBL19747898 0.92 AR (0.52) ARPARP1ENPP1LMNAHDAC1
SCHEMBL19748800 0.92 PARP1 (0.45) ARPARP1PARP2TUBB4ATUBB
SCHEMBL19748900 0.91 PARP1 (0.43) ARPARP1PARP2TUBB4ATUBB
SCHEMBL19748244 0.91 PARP1 (0.43) ARPARP1PARP2TUBB4ATUBB
SCHEMBL19748653 0.91 LMNA (0.43) ARPARP1PARP2TUBB4ATUBB
SCHEMBL19747499 0.90 PARP1 (0.45) ARPARP1PARP2TUBB4ATUBB
SCHEMBL19747649 0.90 PARP1 (0.46) ARPARP1PARP2TUBB4ATUBB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109843874-B Phthalazine derivatives useful as inhibitors of PARP1, PARP2 and/or tubulin for the treatment of cancer 加利福尼亚大学董事会 2022-05-27 CN disclosed